#LungCancer changed Tony Goldwyn’s life forever when he lost his mother to the disease.

That’s why he's speaking out this #LungCancerAwarenessMonth—and why he hopes you will too. 🩵

It’s easier than ever using our social media toolkit: socialpresskit.com/go2forlungca...

#LungCancer in young adults is on the rise—even without traditional risk factors.

📅 Oct. 21: Join the next Lung Cancer Living Room® to hear directly from patient advocates sharing their experiences and breaking stigma.

🔗 RSVP: events.go2.org/2025OctoberL...

The 2025 Centers of Excellence Summit kicks off today! 🚀

This year’s theme, Strength in Unity, Empowering Communities, unites professionals & advocates to learn, connect, & grow.

Thanks to our sponsors: @amgen.bsky.social, @astra-zeneca.bsky.social, & @johnsonandjohnson.bsky.social 👏

#COESummit

In this month’s Lung Cancer Living Room®, we’re joined by D. Kyle Hogarth, MD, FCCP, for a conversation about what pulmonary care really looks like for people living with lung cancer.

🗓 Tuesday, August 19
🕔 In-person and virtual: 5:30 p.m. PT/8:30 p.m. ET
🔗 RSVP today: go2.org/living-room/...

The @fda.gov just approved a new treatment for a rare form of #NonSmallCellLungCancer.

🎥 Watch to learn more.

More details ➡️ go2.org/blog/fda-app...

🫁 Know the facts.
⏱️ Don’t wait. Talk to your doctor today to see if you’re eligible for screening. Early detection saves lives, and so does awareness.

Learn more: go2.org/risk-early-d...

🚨 BREAKING: @FDA granted accelerated approval to Datroway (datopotamab deruxtecan-dlnk) for EGFR-positive NSCLC.

This antibody-drug conjugate therapy offers new hope for patients who’ve already tried EGFR-targeted therapy & chemo.

Learn more: tinyurl.com/36cukkrv